Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients
Top Cited Papers
Open Access
- 31 July 2021
- journal article
- letter
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 22 (1), 322-323
- https://doi.org/10.1111/ajt.16775
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesAnnals of Internal Medicine, 2021
- Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ TransplantsAnnals of Internal Medicine, 2021
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant RecipientsThe New England Journal of Medicine, 2021
- Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipientsAmerican Journal of Transplantation, 2021
- Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike proteinJournal of Clinical Virology, 2020